ACE inhibition in stable coronary artery disease [2] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 9, 2005, Pages 937-939

  Yusuf, Salim ^a   Pogue, Janice ^a   Myers, Martin G ^b   McCullough, Craig ^c   Pfeffer, Marc A ^d   Domanski, Michael J ^e   Braunwald, Eugene ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c Venice Internal Medicine   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; TRANDOLAPRIL; INDOLE DERIVATIVE;

CLINICAL TRIAL; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; ENZYME INHIBITION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REINFARCTION; HUMAN; LETTER; META ANALYSIS; MORTALITY; OUTCOMES RESEARCH; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVASCULARIZATION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; STROKE; CARDIOVASCULAR DISEASE; NOTE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; HUMANS; INDOLES; META-ANALYSIS; RISK FACTORS;

EID: 14544292030     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200503033520919     Document Type: Letter

References (0)